China National Pharmaceutical Group (Sinopharm): Net profit for the first half of 2025 was 672 million yuan, a decrease of 6.46% year-on-year.

China National Pharmaceutical Group Corporation announced that its operating income in the first half of 2025 was 4.878 billion yuan, a year-on-year decrease of 18.16%. Net profit was 672 million yuan, a year-on-year decrease of 6.46%. Based on a total share capital of 1.341 billion shares as of June 30, 2025, a total cash dividend of 134 million yuan will be distributed.